{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:05:07Z","timestamp":1776942307154,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.phymed.2013.04.020","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T19:15:33Z","timestamp":1370546133000},"page":"992-998","source":"Crossref","is-referenced-by-count":22,"title":["Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Yang","family":"Quanjun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Lili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Zhiyong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Liya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2013.04.020_bib0005","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ejphar.2011.07.007","article-title":"Anti-inflammatory therapies in cancer cachexia","volume":"668","author":"Argil\u00e9s","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phymed.2013.04.020_bib0155","series-title":"Cachexia and Wasting: A Modern Approach","first-page":"467","article-title":"The role of cytokines in cancer cachexia","author":"Argil\u00e9s","year":"2006"},{"key":"10.1016\/j.phymed.2013.04.020_bib0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/SPC.0b013e3283196ac2","article-title":"Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia","volume":"2","author":"Attaix","year":"2008","journal-title":"Current Opinion in Supportive and Palliative Care"},{"key":"10.1016\/j.phymed.2013.04.020_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phymed.2013.04.020_bib0025","first-page":"1704","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science Signalling"},{"key":"10.1016\/j.phymed.2013.04.020_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:DRUG.0000026256.38560.be","article-title":"Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer","volume":"22","author":"Curry","year":"2004","journal-title":"Investigational New Drugs"},{"key":"10.1016\/j.phymed.2013.04.020_bib0035","doi-asserted-by":"crossref","first-page":"C1376","DOI":"10.1152\/ajpcell.00154.2002","article-title":"Altered expression of skeletal muscle myosin isoforms in cancer cachexia","volume":"283","author":"Diffee","year":"2002","journal-title":"American Journal of Physiology \u2013 Cell Physiology"},{"key":"10.1016\/j.phymed.2013.04.020_bib0040","doi-asserted-by":"crossref","first-page":"39713","DOI":"10.1074\/jbc.M101985200","article-title":"Cysteine 38 in p65\/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones","volume":"276","author":"Garcia-Pineres","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.phymed.2013.04.020_bib0045","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.4049\/jimmunol.163.10.5617","article-title":"The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex","volume":"163","author":"Hehner","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.phymed.2013.04.020_bib0050","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1152\/ajpregu.1998.274.1.R30","article-title":"Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors","volume":"274","author":"Hobler","year":"1998","journal-title":"American Journal of Physiology \u2013 Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.phymed.2013.04.020_bib0055","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-09-0133","article-title":"Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo","volume":"8","author":"Idris","year":"2009","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.phymed.2013.04.020_bib0060","first-page":"67","article-title":"Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients","volume":"1000","author":"Iwase","year":"2004","journal-title":"Lung"},{"key":"10.1016\/j.phymed.2013.04.020_bib0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/CAD.0b013e328356cad9","article-title":"Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide","volume":"23","author":"Kreuger","year":"2012","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.phymed.2013.04.020_bib0070","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/13543780903018880","article-title":"Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate","volume":"18","author":"Li","year":"2009","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.phymed.2013.04.020_bib0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/jpet.108.147934","article-title":"Modulation of DNA methylation by a sesquiterpene lactone parthenolide","volume":"329","author":"Liu","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.phymed.2013.04.020_bib0080","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1828::AID-CNCR28>3.0.CO;2-Z","article-title":"Proinflammatory cytokines, nutritional support, and the cachexia syndrome","volume":"79","author":"Moldawer","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.phymed.2013.04.020_bib0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: pathophysiology and clinical relevance","volume":"83","author":"Morley","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.phymed.2013.04.020_bib0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/14728210903369351","article-title":"Update on emerging drugs for cancer cachexia","volume":"14","author":"Murphy","year":"2009","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1016\/j.phymed.2013.04.020_bib0095","first-page":"233","article-title":"Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells","volume":"59","author":"Parada-Turska","year":"2007","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.phymed.2013.04.020_bib0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/rr67","article-title":"Tumor necrosis factor-\u03b1 and muscle wasting: a cellular perspective","volume":"2","author":"Reid","year":"2001","journal-title":"Respiratory Research"},{"key":"10.1016\/j.phymed.2013.04.020_bib0105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1165\/rcmb.2006-0323OC","article-title":"Parthenolide inhibits IkappaB kinase NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice","volume":"36","author":"Saadane","year":"2007","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.phymed.2013.04.020_bib0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.phymed.2012.05.016","article-title":"NF-\u03baB dependent anti-inflammatory activity of chlorojanerin isolated from Saussurea heteromalla","volume":"19","author":"Saklani","year":"2012","journal-title":"Phytomedicine: International Journal of Phytotherapy and Phytopharmacology"},{"key":"10.1016\/j.phymed.2013.04.020_bib0115","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/pros.20482","article-title":"Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model","volume":"66","author":"Shanmugam","year":"2006","journal-title":"The Prostate"},{"key":"10.1016\/j.phymed.2013.04.020_bib0120","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/pros.21141","article-title":"A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species","volume":"70","author":"Shanmugam","year":"2010","journal-title":"The Prostate"},{"key":"10.1016\/j.phymed.2013.04.020_bib0125","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1097\/01.CCM.0000085186.14867.F7","article-title":"Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis","volume":"31","author":"Sheehan","year":"2003","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.phymed.2013.04.020_bib0130","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0278-6915(03)00146-7","article-title":"Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew)","volume":"41","author":"Smolinski","year":"2003","journal-title":"Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association"},{"key":"10.1016\/j.phymed.2013.04.020_bib0135","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.phymed.2013.04.020_bib0140","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4049\/jimmunol.150.6.2341","article-title":"Mechanisms of experimental cancer cachexia local involvement of IL-1 in colon-26 tumor","volume":"150","author":"Strassmann","year":"1993","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.phymed.2013.04.020_bib0145","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/1535-7163.MCT-05-0030","article-title":"The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer","volume":"4","author":"Sweeney","year":"2005","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.phymed.2013.04.020_bib0150","first-page":"143","article-title":"Natural products and anti-inflammatory activity","volume":"15","author":"Yuan","year":"2006","journal-title":"Asia Pacific Journal of Clinical Nutrition"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711313001980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711313001980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T07:22:39Z","timestamp":1688282559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711313001980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0944711313001980"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2013.04.020","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}